Epicore Biosystems – a digital health solutions leader developing advanced sweat-sensing wearables – announced an additional $6 million in Series B funding, bringing its total Series B raise to $32 million. The follow-on funding round includes new backing from a San Francisco-based investor and several marquee angel investors, along with continued support from Alumni Ventures and Joyance Partners.
What the funding will be used for: This latest funding follows Epicore’s initial $26 million Series B raise led by the Steele Foundation for Hope, and positions the company to accelerate its global expansion and scale next-generation sweat-sensing technologies.
Value proposition: Epicore wearables measure sweat composition and fluid losses, and important physiological markers like skin temperature, motion and thermal flux to detect early signs of fatigue, heat exhaustion and performance. And the impact of its flagship product Connected Hydration has been detailed for industrial workers and athletes. Connected Hydration is the first smart wearable solution to capture new hydration data streams and deliver real-time haptic alerts to guide personalized hydration routines, helping wearers stay ahead of their cognitive and physical recovery needs.
With the new funding, Epicore is focused on key growth initiatives, including:
— Expanding its Connected Hydration solution into industrial markets in Australia, the Middle East and Asia
— Scaling real-time cloud analytics with personalized hydration guidance and recommendations
— Validating novel biomarkers for applications in kidney health and stress management
Epicore’s sweat-sensing wearables also includes the Gx Sweat Patch, commercialized in partnership with PepsiCo and Gatorade for hydration and wellness management of athletes, the Discovery Patch Sweat Collection System (FDA Class I registered) for clinical trials and the Connected Hydration wearable and cloud platform tailored for industrial workers. And these solutions provide real-time point measurements and continuous monitoring capabilities that address the full spectrum of needs for physically demanding occupations and wellness applications.
Enterprise partners: Epicore’s current list of enterprise partners includes Chevron, PepsiCo, Gatorade, United Airlines, Bechtel, Denka, Nitto, the U.S. Air Force, the Office of Naval Research and the U.S. Army. And its biowearable solutions are deployed worldwide across energy, construction, manufacturing, aviation and shipping sectors.
KEY QUOTES:
“Connected Hydration seamlessly captures multiple sweat and physiology biomarkers, and provides real-time haptic feedback, allowing the wearer to manage their hydration, fatigue, and recovery needs. We’re thrilled to have mission-driven investors onboard who recognize both the value of new data streams and the utility of biosensor technologies to transform safety, well-being and productivity.”
Dr. Roozbeh Ghaffari, CEO and co-founder of Epicore Biosystems
“Epicore’s biosensing technologies deliver precisely what large industries and enterprises need — science-backed digital tools to protect workers, boost productivity and improve lives. We are proud to support the team’s efforts to fundamentally transform the way we approach hydration health, wellness and performance at a global scale.”
Michael Edelhart, managing director of Joyance Partners
